SEC Form 4 · accession 0001479791-17-000006
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 27, 2017
Accepted (ET)
Dec 29, 2017 · 11:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Dec 27, 2017 | S | 10,000 | $0.165 | D | 26,183,122 | D |
Table II — derivative securities
No Table II lines on this filing.